Lexaria: oral GLP-1 drugs could reach $89 billion market by 2034
Lexaria cited Grandview Research data showing the oral GLP-1 market could reach $89 billion by 2034, from about $5.1 billion currently, assuming 35% oral penetration.
Lexaria cited Grandview Research data showing the oral GLP-1 market could reach $89 billion by 2034, from about $5.1 billion currently, assuming 35% oral penetration.